JP2025131566A5 - - Google Patents
Info
- Publication number
- JP2025131566A5 JP2025131566A5 JP2025075147A JP2025075147A JP2025131566A5 JP 2025131566 A5 JP2025131566 A5 JP 2025131566A5 JP 2025075147 A JP2025075147 A JP 2025075147A JP 2025075147 A JP2025075147 A JP 2025075147A JP 2025131566 A5 JP2025131566 A5 JP 2025131566A5
- Authority
- JP
- Japan
- Prior art keywords
- human subject
- tau
- administered
- dose
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135932P | 2021-01-11 | 2021-01-11 | |
| US63/135,932 | 2021-01-11 | ||
| US202163155029P | 2021-03-01 | 2021-03-01 | |
| US63/155,029 | 2021-03-01 | ||
| US202163160380P | 2021-03-12 | 2021-03-12 | |
| US63/160,380 | 2021-03-12 | ||
| US202163192262P | 2021-05-24 | 2021-05-24 | |
| US63/192,262 | 2021-05-24 | ||
| US202163227054P | 2021-07-29 | 2021-07-29 | |
| US63/227,054 | 2021-07-29 | ||
| US202163277298P | 2021-11-09 | 2021-11-09 | |
| US63/277,298 | 2021-11-09 | ||
| US202163284248P | 2021-11-30 | 2021-11-30 | |
| US63/284,248 | 2021-11-30 | ||
| US202263296694P | 2022-01-05 | 2022-01-05 | |
| US63/296,694 | 2022-01-05 | ||
| PCT/US2022/011894 WO2022150735A1 (en) | 2021-01-11 | 2022-01-11 | Anti-n3pglu amyloid beta antibodies and uses thereof |
| JP2023541749A JP7676556B2 (ja) | 2021-01-11 | 2022-01-11 | 抗Ｎ３ｐＧｌｕアミロイドベータ抗体及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541749A Division JP7676556B2 (ja) | 2021-01-11 | 2022-01-11 | 抗Ｎ３ｐＧｌｕアミロイドベータ抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025131566A JP2025131566A (ja) | 2025-09-09 |
| JP2025131566A5 true JP2025131566A5 (https=) | 2025-12-02 |
Family
ID=80123357
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541749A Active JP7676556B2 (ja) | 2021-01-11 | 2022-01-11 | 抗Ｎ３ｐＧｌｕアミロイドベータ抗体及びその使用 |
| JP2025075147A Pending JP2025131566A (ja) | 2021-01-11 | 2025-04-30 | 抗Ｎ３ｐＧｌｕアミロイドベータ抗体及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541749A Active JP7676556B2 (ja) | 2021-01-11 | 2022-01-11 | 抗Ｎ３ｐＧｌｕアミロイドベータ抗体及びその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240010713A1 (https=) |
| EP (1) | EP4274611A1 (https=) |
| JP (2) | JP7676556B2 (https=) |
| KR (2) | KR20260047659A (https=) |
| AU (1) | AU2022206461B2 (https=) |
| CA (1) | CA3204444A1 (https=) |
| CL (1) | CL2023001992A1 (https=) |
| CO (1) | CO2023009089A2 (https=) |
| EC (1) | ECSP23051813A (https=) |
| IL (1) | IL304072A (https=) |
| MX (1) | MX2023008196A (https=) |
| PE (1) | PE20231748A1 (https=) |
| TW (1) | TWI843040B (https=) |
| WO (1) | WO2022150735A1 (https=) |
| ZA (1) | ZA202306180B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022307687A1 (en) * | 2021-07-09 | 2024-01-04 | Eisai R&D Management Co., Ltd. | Biomarkers for alzheimer's disease treatment |
| WO2023039107A2 (en) | 2021-09-09 | 2023-03-16 | Alzpath, Inc. | Phospho-tau antibodies and methods of use |
| CA3243602A1 (en) * | 2022-02-03 | 2023-08-10 | Eli Lilly And Company | Regional Tau Imaging for the Diagnosis and Treatment of Alzheimer's Disease |
| KR20250107906A (ko) * | 2022-11-17 | 2025-07-14 | 일라이 릴리 앤드 캄파니 | 항-N3pGlu 아밀로이드 베타 항체, 그의 용량 및 용도 |
| KR20250173598A (ko) * | 2023-03-16 | 2025-12-10 | 알즈패스, 인크. | 신경퇴행성 질환의 진단 및 치료 방법 |
| WO2025231343A1 (en) * | 2024-05-03 | 2025-11-06 | Therini Bio, Inc. | Doses of antibodies which bind human fibrin yc or fibrinogen yc domain for neurodegenerative diseases |
| WO2025240435A1 (en) * | 2024-05-14 | 2025-11-20 | Othair Prothena Limited | Methods of treating neurological disorders with anti-abeta antibodies |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1257584T1 (de) | 2000-02-24 | 2003-05-28 | Lilly Co Eli | Humanisierte antikörper, die amyloid beta peptid demarkieren |
| PT1944040E (pt) | 2001-08-17 | 2012-10-31 | Univ Washington | Método de avaliação para a doença de alzheimer |
| SI1720909T1 (sl) | 2004-02-23 | 2012-01-31 | Lilly Co Eli | Anti-abeta protitelo |
| WO2010009987A2 (en) | 2008-07-21 | 2010-01-28 | Probiodrug Ag | Diagnostic antibody assay |
| WO2011151076A2 (en) | 2010-06-04 | 2011-12-08 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS |
| PL3042917T3 (pl) | 2010-08-12 | 2018-07-31 | Eli Lilly And Company | Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie |
| WO2012021475A2 (en) * | 2010-08-12 | 2012-02-16 | Eli Lilly And Company | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| US9499610B2 (en) | 2011-04-08 | 2016-11-22 | H. Lundbeck A/S | Antibodies specific to pyroglutamated Aβ |
| JOP20170004B1 (ar) | 2016-01-15 | 2022-09-15 | Lilly Co Eli | الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته |
| TWI798751B (zh) * | 2016-07-01 | 2023-04-11 | 美商美國禮來大藥廠 | 抗－N3pGlu類澱粉β肽抗體及其用途 |
| TWI789644B (zh) | 2017-04-20 | 2023-01-11 | 美商美國禮來大藥廠 | 抗－N3pGlu類澱粉β肽抗體及其用途 |
| CN107289872A (zh) | 2017-06-28 | 2017-10-24 | 京东方科技集团股份有限公司 | 测高装置 |
| KR102905634B1 (ko) | 2019-05-31 | 2025-12-30 | 일라이 릴리 앤드 캄파니 | 인간 타우를 표적화하는 화합물 및 방법 |
-
2022
- 2022-01-10 TW TW111101008A patent/TWI843040B/zh active
- 2022-01-11 IL IL304072A patent/IL304072A/en unknown
- 2022-01-11 KR KR1020267008447A patent/KR20260047659A/ko active Pending
- 2022-01-11 AU AU2022206461A patent/AU2022206461B2/en active Active
- 2022-01-11 CA CA3204444A patent/CA3204444A1/en active Pending
- 2022-01-11 WO PCT/US2022/011894 patent/WO2022150735A1/en not_active Ceased
- 2022-01-11 JP JP2023541749A patent/JP7676556B2/ja active Active
- 2022-01-11 US US18/260,125 patent/US20240010713A1/en active Pending
- 2022-01-11 EP EP22701816.5A patent/EP4274611A1/en active Pending
- 2022-01-11 KR KR1020237027055A patent/KR102942744B1/ko active Active
- 2022-01-11 MX MX2023008196A patent/MX2023008196A/es unknown
- 2022-01-11 PE PE2023002030A patent/PE20231748A1/es unknown
-
2023
- 2023-06-12 ZA ZA2023/06180A patent/ZA202306180B/en unknown
- 2023-07-06 CL CL2023001992A patent/CL2023001992A1/es unknown
- 2023-07-07 CO CONC2023/0009089A patent/CO2023009089A2/es unknown
- 2023-07-10 EC ECSENADI202351813A patent/ECSP23051813A/es unknown
-
2025
- 2025-04-30 JP JP2025075147A patent/JP2025131566A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025131566A5 (https=) | ||
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| US12084491B2 (en) | Treatment of Parkinson's disease | |
| US20220062412A1 (en) | Treatment of alzheimer's disease (ad) with an aluminum salt | |
| US9968582B2 (en) | Use of a benzoate containing composition in urea cycle disorders and neurodegenerative disorders | |
| KR20140121475A (ko) | 특발성 염증성 근질환의 예방 또는 치료제 | |
| IL305764A (en) | Anti-amyloid beta antibodies and their uses. | |
| JP2022092013A (ja) | アルツハイマー病を治療するための抗ａベータプロトフィブリル抗体及びベータ－セクレターゼｂａｃｅ１阻害剤を含む組成物 | |
| EA034394B1 (ru) | Биотин для лечения амиотрофического латерального склероза | |
| US20220000908A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| JP2024540294A5 (https=) | ||
| MXPA97003810A (en) | A medicine that comprises a carnitin derivative to treat alzheimer's disease in patients with premat start | |
| EP0808626A1 (en) | Use of acetyl-L-carnitine for the treatment of presenile Alzheimer's disease | |
| Johnson | A review of the clinical efficacy profile of copolymer 1: new US phase III trial data | |
| AU2015254663B2 (en) | Treatment and prevention of Alzheimer's Disease (AD) | |
| Weiner et al. | ACE inhibitor lacks acute effect on cognition or brain blood flow in Alzheimer's disease | |
| CN114984034A (zh) | 一种寡糖类化合物的应用 | |
| US8664209B2 (en) | Daptomycin for multiple sclerosis | |
| US20240101644A1 (en) | The use of intravenous immunoglobulin in the preparation of a drug for the treatment of cutis verticis gyrata disease | |
| Shalamberidze | 372 Is hyperventilation the reason for seizures during cyanotic breathholding spells? | |
| Casper et al. | 527. Family relationship characteristics in anorexia nervosa | |
| Walker | Acquired Choreas | |
| STROKE | Clinical Updates in Neuropsychiatry | |
| Weiner et al. | Department zyxwvutsrqponmlk | |
| Roncallo et al. | Acute Disseminated Encephalomyelitis: Clinical, CSF, and MRI Findings and the Distinction from Multiple Sclerosis |